SCHEMBL6463167

SCHEMBL6463167

COCCNC(=O)c1cc(-c2ccc(Cl)cc2)cs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALAD P13716 1/20 0.55
HPGD P15428 4/20 0.54
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
HSD17B10 Q99714 3/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
IKBKE Q14164 1/20 0.52
AURKB Q96GD4 1/20 0.52
TBK1 Q9UHD2 1/20 0.52
MMP12 P39900 5/20 0.51
MMP2 P08253 1/20 0.51
MMP8 P22894 1/20 0.51
MMP13 P45452 1/20 0.51
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6450947 0.87 MMP12 (0.65) HPGDALDH1A1HSD17B10MAPTIKBKE
SCHEMBL6456265 0.80 NPC1 (0.57) ALADMAPTMMP12NPC1RAB9A
SCHEMBL21563725 0.79 ALAD (0.66) ALADKDM4EALDH1A1GAAMAPT
SCHEMBL6704697 0.79 ALAD (0.71) ALADKDM4EALDH1A1MAPTNPC1
SCHEMBL24731402 0.77 IKBKE (0.46) HPGDKDM4EALDH1A1GAAIKBKE
SCHEMBL6457123 0.75 MMP12 (0.82) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL15177354 0.74 ALAD (0.72) ALADHPGDALDH1A1GAAMAPT
SCHEMBL13267656 0.73 ALAD (0.66) ALADMAPTMAPK1SMN1; SMN2ULK1
SCHEMBL2652069 0.72 ALAD (1.00) ALADKDM4EMMP12MMP13NPC1
SCHEMBL24176394 0.70 ALAD (0.72) ALADMAPTIKBKEAURKBTBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534700-A1 NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME WARNER-LAMBERT COMPANY LLC (US) 2005-06-01 EP claimed
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them WARNER-LAMBERT COMPANY LLC 2004-04-15 US claimed
WO-2004018448-A1 NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME WARNER-LAMBERT COMPANY LLC (US) 2004-03-04 WO claimed
EP-1534700-A1 NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME WARNER-LAMBERT COMPANY LLC (US) 2005-06-01 EP disclosed
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them WARNER-LAMBERT COMPANY LLC 2004-04-15 US disclosed
WO-2004018448-A1 NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME WARNER-LAMBERT COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them MMP11, MMP13, CBR1 ALAD 3624/4885HPGD 612/4885KDM4E 2797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.